Stay updated on Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:43:41.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the expected study details with an access-block message.
    Difference
    18%
    Check dated 2026-09-23T00:52:56.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The revision line on the page updates from v3.6.6 to v3.7.0, indicating a routine page revision rather than a change to study information or layout.
    Difference
    0.1%
    Check dated 2026-09-16T00:09:25.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.5 to v3.6.6, indicating a newer version of the ClinicalTrials.gov entry. This appears to be a metadata update rather than a change to study details or visible content.
    Difference
    0.1%
    Check dated 2026-09-01T19:30:21.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5, replacing the previous v3.6.4, indicating a small update to the page's underlying version.
    Difference
    0.1%
    Check dated 2026-08-11T21:40:17.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The page's revision line updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a newer build/version of the page. This reflects an update to the page's revision history rather than a substantive content change.
    Difference
    0.1%
    Check dated 2026-07-28T15:40:48.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page.